NASDAQ:NTLA

Intellia Therapeutics Insider Trades

$132.37
-1.63 (-1.22 %)
(As of 07/27/2021 12:00 AM ET)
Add
Compare
Today's Range
$125.68
$135.12
50-Day Range
$63.48
$171.65
52-Week Range
$16.54
$202.73
Volume1.08 million shs
Average Volume1.89 million shs
Market Capitalization$9.02 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.11

Intellia Therapeutics (NASDAQ:NTLA) Insider Buying and Selling Activity

5.10% of Intellia Therapeutics' shares are owned by company executives, directors and other insiders. Over the past twelve months, Intellia Therapeutics insiders have sold shares 32 time(s), totalling $172,035,403.40. Insiders that have sold shares include Jean Francois Formela, Caroline Dorsa, John M Leonard, Jose E Rivera, Andrew Schiermeier, Jose E. Rivera, and Perry A Karsen.

Insider Buying and Selling by Quarter


Intellia Therapeutics (NASDAQ NTLA) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/28/2021Jean Francois FormelaDirectorSell553,376$132.73$73,449,596.48  
6/14/2021Jean Francois FormelaDirectorSell170,779$87.37$14,920,961.23  
6/11/2021Jean Francois FormelaDirectorSell30,946$85.23$2,637,527.58  
4/28/2021Jean Francois FormelaDirectorSell131,926$85.56$11,287,588.56  
4/26/2021Jean Francois FormelaDirectorSell806$84.93$68,453.58  
4/5/2021Caroline DorsaDirectorSell7,500$82.19$616,425.0012,910  
4/1/2021John M LeonardCEOSell38,209$83.64$3,195,800.76705,536  
4/1/2021Jose E RiveraEVPSell50,455$82.46$4,160,519.30148,842  
2/26/2021Jean Francois FormelaDirectorSell501,945$60.29$30,262,264.05  
2/9/2021John M LeonardCEOSell28,043$75.00$2,103,225.00654,803  
2/9/2021Jose E RiveraEVPSell11,489$75.00$861,675.00129,409  
2/5/2021John M LeonardCEOSell22,942$67.66$1,552,255.72654,803  
2/3/2021John M LeonardCEOSell67,856$72.54$4,922,274.24575,488  
2/1/2021John M LeonardCEOSell109,889$64.00$7,032,896.00575,488  
2/1/2021Jose E RiveraEVPSell54,659$63.99$3,497,629.41120,068  
1/5/2021Andrew SchiermeierCOOSell1,377$55.86$76,919.22  
1/5/2021John M LeonardCEOSell6,239$55.86$348,510.54481,727  
1/5/2021Jose E. RiveraEVPSell2,078$55.86$116,077.08  
12/17/2020Perry A KarsenDirectorSell88,764$53.55$4,753,312.2036,764  
12/1/2020Jose E RiveraEVPSell3,364$38.21$128,538.4452,072  
11/27/2020John M LeonardCEOSell35,000$38.57$1,349,950.00482,352  
11/25/2020John M LeonardCEOSell50,000$36.00$1,800,000.00517,352  
11/18/2020Jose E RiveraEVPSell624$35.00$21,840.0052,315  
11/16/2020John M LeonardCEOSell20,000$34.00$680,000.00487,352  
11/16/2020Jose E RiveraEVPSell6,029$34.29$206,734.4152,315  
11/4/2020John M LeonardCEOSell50,000$26.00$1,300,000.00517,352  
11/4/2020Jose E RiveraEVPSell3,364$28.00$94,192.0045,679  
10/15/2020Jose E RiveraEVPSell5,615$24.20$135,883.0046,294  
10/7/2020John M LeonardCEOSell5,000$21.83$109,150.00472,352  
9/15/2020Jose E RiveraEVPSell5,615$21.04$118,139.6041,909  
8/18/2020Jose E RiveraEVPSell5,615$21.00$117,915.0037,524  
8/6/2020John M LeonardCEOSell5,000$21.83$109,150.00472,352  
7/15/2020Jose E. RiveraEVPSell5,615$22.70$127,460.50  
7/1/2020John M LeonardCEOSell5,000$21.83$109,150.00472,352  
6/16/2020Jose E RiveraEVPSell5,615$21.00$117,915.0027,897  
6/3/2020John M LeonardCEOSell5,000$21.83$109,150.00472,352  
5/26/2020Jose E. RiveraEVPSell5,615$21.21$119,094.15  
3/6/2019Andrew SchiermeierEVPBuy7,500$15.72$117,900.003,250  
7/16/2018Jean Francois FormelaDirectorSell6,686$31.17$208,402.62  
6/19/2018Jean Francois FormelaDirectorSell6,686$27.96$186,940.56  
5/16/2018Jean Francois FormelaDirectorSell6,686$25.04$167,417.44  
5/14/2018John M. LeonardInsiderSell8,400$24.00$201,600.00  
3/20/2018Jean Francois FormelaDirectorSell39,245$23.87$936,778.15  
1/29/2018Caribou Biosciences, Inc.Major ShareholderSell550,645$26.78$14,746,273.10  
12/12/2017Institutes For Biomed NovartisMajor ShareholderSell1,523,000$18.30$27,870,900.00  
12/8/2017Nessan BerminghamCEOSell336,783$20.78$6,998,350.74696,000  
12/6/2017Nessan BerminghamCEOSell111,500$20.34$2,267,910.00696,000  
7/11/2017Venture Fund Ix L.P. AtlasMajor ShareholderSell150,000$16.24$2,436,000.00  
3/10/2017Jean Francois FormelaDirectorSell21,132$13.91$293,946.12  
5/11/2016Bros. Advisors Lp BakerInsiderBuy200,000$18.00$3,600,000.00  
5/11/2016Carl L GordonDirectorBuy250,000$18.00$4,500,000.00  
5/11/2016Institutes For Biomed NovartisMajor ShareholderBuy277,777$18.00$4,999,986.00  
(Data available from 1/1/2013 forward)
This page was last updated on 7/28/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.